Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amrix for the Treatment of Chronic Migraine
NCT01151787Phase 3Terminated
- Sponsor
- Kennedy Medical Group
- Start
- Jul 2010
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic migraine comparing cyclobenzaprine hydrochloride with placebo (2 arms). Primary endpoint: Mean total number of migraine/migrainous headache days per month at 4 months. Started Jul 2010; status: terminated.
02
Drugs
cyclobenzaprine
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT01151787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01151787.